Abstract
(2014). Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection. Expert Review of Anti-infective Therapy: Vol. 12, No. 9, pp. 1033-1043. doi: 10.1586/14787210.2014.940898

This publication has 77 references indexed in Scilit: